Form 8-K - Current report:
SEC Accession No. 0001213900-20-009707
Filing Date
2020-04-21
Accepted
2020-04-21 16:10:19
Documents
2
Period of Report
2020-04-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea120914-8k_inmunebio.htm 8-K 17905
2 TRANSCRIPT OF THE INMUNE BIO INC. CONFERENCE CALL ON APRIL 20, 2020 ea120914ex99-1_inmune.htm EX-99.1 82383
  Complete submission text file 0001213900-20-009707.txt   101401
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 20805255
SIC: 2836 Biological Products, (No Diagnostic Substances)